Items where authors include "Fernandez, C."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Wright-Hughes, A. orcid.org/0000-0001-8839-6756, Ow, P.-L., Alderson, S.L. et al. (11 more authors) (2025) Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial. Gut. ISSN 0017-5749

Gale, C.P., Stocken, D.D., Aktaa, S. et al. (11 more authors) (2024) Effectiveness of the GRACE risk score according to troponin elevation in patients admitted with non-ST elevation acute coronary syndrome: a post-hoc analysis of the UKGRIS cluster RCT. European Heart Journal, 45 (Supplement_1). ehae666.1690. ISSN 0195-668X

Wright-Hughes, A. orcid.org/0000-0001-8839-6756, Ford, A.C. orcid.org/0000-0001-6371-4359, Alderson, S.L. orcid.org/0000-0002-5418-0495 et al. (19 more authors) (2024) Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT. Health Technology Assessment, 28 (66). ISSN 1366-5278

Teasdale, E., Everitt, H., Alderson, S. et al. (19 more authors) (2024) Low-dose amitriptyline for irritable bowel syndrome (IBS): a qualitative study of patients' and GPs' views and experiences. British Journal of General Practice. BJGP.2024.0303. ISSN 0960-1643

Useche, S.A. orcid.org/0000-0002-5099-4627, Alonso, F. orcid.org/0000-0002-9482-8874, Boyko, A. et al. (32 more authors) (2024) Using demographic, psychosocial, behavioural and safety-related factors to assess cyclists' behaviour: A comparative approach across 19 countries. Data in Brief, 54. 110278. ISSN 2352-3409

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Pontarini, E. orcid.org/0000-0003-0439-0344, Sciacca, E. orcid.org/0000-0001-7525-1558, Chowdhury, F. et al. (28 more authors) (2024) Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS). Arthritis & Rheumatology, 76 (5). pp. 763-776. ISSN 2326-5191

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Ford, A.C., Wright-Hughes, A., Alderson, S.L. et al. (65 more authors) (2023) Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 402 (10414). pp. 1773-1785. ISSN 0140-6736

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Everett, C.C., Berry, C., McCann, G.P. orcid.org/0000-0002-5542-8448 et al. (14 more authors) (2023) Randomised trial of stable chest pain investigation: 3-year clinical and quality of life results from CE-MARC 2. Open Heart, 10 (1). ARTN e002221. ISSN 2053-3624

Ajjan, R.A. orcid.org/0000-0002-1636-3725, Heller, S.R. orcid.org/0000-0002-2425-9565, Everett, C.C. et al. (11 more authors) (2023) Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial. Diabetes Care, 46 (2). pp. 441-449. ISSN 0149-5992

Ajjan, R.A. orcid.org/0000-0002-1636-3725, Heller, S.R. orcid.org/0000-0002-2425-9565, Everett, C.C. et al. (11 more authors) (2023) Multicenter randomized trial of intermittently scanned continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes and recent-onset acute myocardial infarction: results of the LIBERATES trial. Diabetes Care, 46 (2). dc221219. ISSN 0149-5992

Meng, B., Abdullahi, A., Ferreira, I.A.T.M. et al. (219 more authors) (2022) Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature, 603 (7902). pp. 706-714. ISSN 0028-0836

Smith, I.L. orcid.org/0000-0002-8326-1075, Gilberts, R. orcid.org/0000-0003-3326-7900, Brown, S. orcid.org/0000-0002-1840-3786 et al. (14 more authors) (2022) Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial. BMJ Open, 12 (2). e060029. ISSN 2044-6055

Everett, C.C., Reynolds, C., Fernandez, C. et al. (6 more authors) (2020) Rationale and design of the LIBERATES trial : protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarction. Diabetes and Vascular Disease Research, 17 (5). ISSN 1479-1641